Human T-cell Lymphotropic Virus Type I and Systemic Lupus Erythematosus

Internal Medicine

Volumn 38, Issue 6, 1999, Pages 459-460

  Ijichi, Shinji ^a   Osame, Mitsuhiro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

autoimmune disease; pathogenesis; retrovirus

Indexed keywords

PROTEIN BCL 2;

BIOSYNTHESIS; CD4+ T LYMPHOCYTE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOLOGY; METABOLISM; NOTE; RISK FACTOR; SPASTIC PARAPLEGIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

CD4-POSITIVE T-LYMPHOCYTES; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PARAPARESIS, TROPICAL SPASTIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RISK FACTORS;

EID: 0033144562     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.459     Document Type: Article

References (24)

1. Shoenfeld Y, Isenberg DA. The mosaic of autoimmunity. Immunol Today 10: 123–126, 1989.
2. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T-cell leukemia virus type I. J Virol 64: 5682–5687, 1990.
3. Newbound GC, Andrews JM, O’Rourke JP, Brady JN, Lairmore MD. Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytes. J Virol 70: 2101–2106, 1996.
4. Ijichi S, Osame M. Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP): recent perspectives. Intern Med 34: 713–721, 1995.
5. Nakagawa M, Izumo S, Ijichi S, et al. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1: 50–61, 1995.
6. Ijichi S. Nakagawa M, Umehara F, et al. HAM/TSP: recent perspectives in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 13 (Suppl 1): S26-S32, 1996.
7. Umehara F, Nakamura A, Izumo S, et al. Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to control viral infection in the central nervous system. J Neuropathol Exp Neurol 53: 617–624, 1994.
8. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 18: 44–51, 1997.
9. Miura T, Tanaka H, Makino Y, et al. Human T cell leukemia virus type I-associated myelopathy in a patient with systemic lupus erythematosus. Intern Med 38: 512–515, 1999.
10. Vernant JC, Buisson GG, Sobesky G, Arfi S, Gervaise G, Roman GC. Can HTLV-1 lead to immunological disease? Lancet 2: 404, 1987 (letter).
11. Takayanagui OM, Moura LS, Petean FC, Biscaro TA, Covas DT, Osame M. Human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis and systemic lupus erythematosus. Neurology 48: 1469–1470, 1997.
12. Irvine W, White P, Cambridge G. Antibodies to HTLV-I in sera from patients with connective tissue diseases. Ann Rheum Dis 48: 80, 1989 (letter).
13. Talarmin A, Nizou J-Y, Kazanji M. Antinuclear autoantibodies in human T-cell leukemia/lymphoma virus type I carriers in French Guiana. Arch Virol 142: 1713–1718, 1997.
14. Takeno M, Nagafuchi H, Kaneko S, et al. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. J Immunol 158: 3529–3538, 1997.
15. Ohsako S, Hara M, Harigai M, Fukasawa C, Kashiwazaki S. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin Immunol Immunopathol 73: 109–114, 1994.
16. Aringer M, Wintersberger W, Steiner CW, et al. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 37: 1423–1430, 1994.
17. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314–317, 1992.
18. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969–976, 1994.
19. Lynch DH, Watson ML, Alderson MR, et al. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1: 131–136, 1994.
20. Higuchi M, Nagasawa K, Horiuchi T, et al. Membrane tumor necrosis factor-a (TNF-a) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation: characterization of membrane TNF-a. Clin Immunol Immunopathol 82: 133–140, 1997.
21. Furukawa Y, Fujisawa M, Osame M, et al. Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-I-associated myelopathy (HAM-TSP). Blood 80: 1012–1016, 1992.
22. Wattel E, Cavrois M, Gessain A, Wain-Hobson S. Clonal expansion of infected cells: a way of life for HTLV-I. J Acquir Immune Defic Syndr Hum Retrovirol 13 (Suppl 1): S92-S99, 1996.
23. Eiraku N, Hingorani R, Ijichi S, et al. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. J Immunol 161: 6674–6680, 1998.
24. Mountz JD, Cheng J, Su X, Wu J, Zhou T. Autoimmunity, apoptosis defects and retroviruses, in: Cell Activation and Apoptosis in HIV Infection, Andrie J-M, Lu W, Eds. Plenum Press, New York, 1995: p. 183–201.